Scholarlink

Introduction <p>Preoperative substance use is increasingly observed among candidates for metabolic and bariatric surgery (MBS), yet its perioperative and 1-year effects remain unclear in the Middle East and North Africa (MENA). We assessed whether routine preoperative urine toxicology screening tests (TSTs) predict anesthetic requirements, recovery, early complications, and 1-year weight loss.</p> Methods <p>Prospective single-center cohort of 1,260 primary MBS patients (Alexandria, Egypt; Dec 2023–May 2024). All underwent urine screening for seven substance classes and were classified as TST-positive or TST-negative. Outcomes included propofol and intraoperative fentanyl doses, recovery metrics, postoperative pain (VAS) and opioid requirements, 30-day complications/readmissions, length of stay, and 1-year percent total and excess weight loss (%TWL, %EWL). Inverse propensity score weighting (IPSW) balanced baseline covariates. One-year outcomes were available for 1,134 of 1,260 patients (90.0%).</p> Results <p>190 out of 1,260 (15.1%) were TST-positive—most commonly tramadol (57.9%) and cannabis (36.8%); 12.1% denied use despite a positive TST. After IPSW adjustment, TST-positive patients required more propofol (mean difference 49.7&#xa0;mg; <i>p</i> &lt; 0.001) and fentanyl (MD 51.2&#xa0;µg; <i>p</i> &lt; 0.001), experienced longer recovery times (MD 5.36&#xa0;min; <i>p</i> &lt; 0.001), had higher postoperative VAS scores and opioid requirements, longer hospital stays (<i>p</i> &lt; 0.001), and increased 30-day complications (5.4% vs. 1.9%; <i>p</i> = 0.015) and readmissions (7.1% vs. 1.6%; <i>p</i> &lt; 0.001).</p> Conclusions <p>Routine preoperative TST identifies patients at risk for increased anesthetic/analgesic needs, delayed recovery, agitation, and higher early morbidity. Incorporating TST into preoperative pathways may optimize perioperative planning in MENA settings.</p> Trial Registration <p>NCT07100314.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of Preoperative Toxicological Screening on Perioperative Anesthetic Management and Short-Term Outcomes Following Metabolic and Bariatric Surgery: A Prospective Observational Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月31日

查看全文
  • Mohamed Hany,
  • Adel Ibrahim Hozien,
  • Heba Abdel Samie Mohamed Hussein,
  • Islam El-Sayes,
  • Engi Yousry Hashem,
  • Ehab Elmongui,
  • Ahmed El Shamarka,
  • Walid El Ansari

摘要

Introduction

Preoperative substance use is increasingly observed among candidates for metabolic and bariatric surgery (MBS), yet its perioperative and 1-year effects remain unclear in the Middle East and North Africa (MENA). We assessed whether routine preoperative urine toxicology screening tests (TSTs) predict anesthetic requirements, recovery, early complications, and 1-year weight loss.

Methods

Prospective single-center cohort of 1,260 primary MBS patients (Alexandria, Egypt; Dec 2023–May 2024). All underwent urine screening for seven substance classes and were classified as TST-positive or TST-negative. Outcomes included propofol and intraoperative fentanyl doses, recovery metrics, postoperative pain (VAS) and opioid requirements, 30-day complications/readmissions, length of stay, and 1-year percent total and excess weight loss (%TWL, %EWL). Inverse propensity score weighting (IPSW) balanced baseline covariates. One-year outcomes were available for 1,134 of 1,260 patients (90.0%).

Results

190 out of 1,260 (15.1%) were TST-positive—most commonly tramadol (57.9%) and cannabis (36.8%); 12.1% denied use despite a positive TST. After IPSW adjustment, TST-positive patients required more propofol (mean difference 49.7 mg; p < 0.001) and fentanyl (MD 51.2 µg; p < 0.001), experienced longer recovery times (MD 5.36 min; p < 0.001), had higher postoperative VAS scores and opioid requirements, longer hospital stays (p < 0.001), and increased 30-day complications (5.4% vs. 1.9%; p = 0.015) and readmissions (7.1% vs. 1.6%; p < 0.001).

Conclusions

Routine preoperative TST identifies patients at risk for increased anesthetic/analgesic needs, delayed recovery, agitation, and higher early morbidity. Incorporating TST into preoperative pathways may optimize perioperative planning in MENA settings.

Trial Registration

NCT07100314.

Graphical Abstract